Home > News > IMAGNA project team started work on therapeutic vaccination against cat fibrosarcoma
September 20th, 2007
IMAGNA project team started work on therapeutic vaccination against cat fibrosarcoma
Abstract:
IMAGNA (immuno gene therapy with magnetic nanoparticles) has been founded by members of the Institute of Experimental Oncology Klinikum rechts der Isar (Technical University Munich), the Clinic of Small Animal Medicine of the Ludwig-Maximilians-Universität (Munich), Bayer Schering Pharma AG (Berlin), chemicell GmbH (Berlin), and PlasmidFactory GmbH & Co. KG (Bielefeld) to provide evidence for the usefulness of therapeutic tumor vaccination by the Magnetofection technology in a clinical study in cats with fibrosarcoma. This consortium is supported by a grant from the German Ministry of Education and Research (BMBF).
Source:
nanowerk.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Discoveries
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Utilizing palladium for addressing contact issues of buried oxide thin film transistors April 5th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Human Interest/Art
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||